Sign in

Rapsinski Lab

@raplab.bsky.social
20 followers 11 following 4 posts

Study ventilator-associated infections and Pseudomonas aeruginosa evolution in the airway of ventilated patients. We use whole genome sequencing, experimental evolution, clinical samples, and in vitro airway epithelial cell models.

PostsRepliesMedia
Rapsinski Lab @raplab.bsky.social · 11/03/2026
Rapsinski Lab representing at @pidsociety.bsky.social annual meeting! @jscioli.bsky.social did a great job and a ton of interest.
061
Rapsinski Lab @raplab.bsky.social · 06/08/2025
Thrilled to announce the @raplab.bsky.social is officially NIH K08 Funded!
020
Rapsinski Lab @raplab.bsky.social · 12/03/2025
Thrilled to have new people helping in the lab. Welcome @jscioli.bsky.social.!!
000
Rapsinski Lab @raplab.bsky.social · 11/02/2025
Paper looking at how Avycaz (ceftazidime-avibactam) can select for cross resistance to other beta-lactam/beta-lactamase inhibitor combinations. @aleciarokes.bsky.social @vscooper.micropopbio.org @dariavantyne.bsky.social Strong start to our P. aeruginosa research! journals.asm.org/doi/10.1128/...
journals.asm.org
Mutations leading to ceftolozane/tazobactam and imipenem/cilastatin/relebactam resistance during in vivo exposure to ceftazidime/avibactam in Pseudomonas aeruginosa | Microbiology Spectrum
Antibiotic resistance is a significant challenge for physicians trying to treat infections. The development of novel antibiotics to treat resistant infections has not been prioritized for decades, limiting treatment options for infections caused by many ...
053
Reposted by Rapsinski Lab
Vaughn Cooper @vscooper.micropopbio.org · 11/02/2025
How does avi-caz treatment lead to broad-spectrum treatment failure? Our awesome Peds ID faculty and labbie @rapskiid.bsky.social shows how, by longitudinal sequencing, genotyping, and phenotyping. Congrats Glenn! @dariavantyne.bsky.social @aleciarokes.bsky.social journals.asm.org/doi/10.1128/...
journals.asm.org
Mutations leading to ceftolozane/tazobactam and imipenem/cilastatin/relebactam resistance during in vivo exposure to ceftazidime/avibactam in Pseudomonas aeruginosa | Microbiology Spectrum
Antibiotic resistance is a significant challenge for physicians trying to treat infections. The development of novel antibiotics to treat resistant infections has not been prioritized for decades, lim...
088
Reposted by Rapsinski Lab
Vaughn Cooper @vscooper.micropopbio.org · 10/02/2025
Many people, including academics, don't understand what F&A is for. Please share to help. 1) Translate to "overhead" in common business accounting: 60% IDC => 60/160 = 37.5% overhead (low!) 2) Infographic explaining what it's for, linked here: www.cogr.edu/sites/defaul...
17760